Pawan Gupta

Employment

• Stempeutics (India)

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 study
  Osteoarthritis and Cartilage Open 2026 DOI: 10.1016/j.ocarto.2025.100723
  +Save
• Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability
  Cytotherapy 2025 DOI: 10.1016/j.jcyt.2025.08.005
  +Save
• Regulatory systems and requirements for clinical trials of AAV-based gene therapies – Perspectives from six Asian countries or regions: Report from the 6th Asia Partnership Conference of Regenerative Medicine – April 20, 2023
  Regenerative Therapy 2024 DOI: 10.1016/j.reth.2024.06.005
  +Save
• Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease
  Stem Cell Research & Therapy 2023 DOI: 10.1186/s13287-023-03292-w
  +Save
• Nonclinical and quality assessment of cell therapy products: Report on the 4th Asia Partnership Conference of Regenerative Medicine, April 15, 2021
  Cytotherapy 2022 DOI: 10.1016/j.jcyt.2022.01.005
  +Save
• The promising role of autologous and allogeneic mesenchymal stromal cells in managing knee osteoarthritis. What is beyond Mesenchymal stromal cells?
  Journal of Clinical Orthopaedics and Trauma 2022 DOI: 10.1016/j.jcot.2022.101804
  +Save